The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000022.4(ADA):c.396dup (p.Val133fs)

CA658824668

550821 (ClinVar)

Gene: ADA
Condition: adenosine deaminase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 4ab2445c-e8c4-479d-87cb-de2f90731ef3
Approved on: 2024-01-17
Published on: 2024-01-17

HGVS expressions

NM_000022.4:c.396dup
NM_000022.4(ADA):c.396dup (p.Val133fs)
NC_000020.11:g.44625651dup
CM000682.2:g.44625651dup
NC_000020.10:g.43254292dup
CM000682.1:g.43254292dup
NC_000020.9:g.42687706dup
NG_007385.1:g.31085dup
ENST00000372874.9:c.396dup
ENST00000372874.8:c.396dup
ENST00000464097.5:n.70dup
ENST00000492931.5:n.480dup
ENST00000536532.5:c.396dup
ENST00000537820.1:c.396dup
ENST00000539235.5:c.219-2573dup
NM_000022.2:c.396dup
NM_000022.3:c.396dup
NM_001322050.1:c.73+805dup
NM_001322051.1:c.396dup
NR_136160.1:n.547dup
NM_001322050.2:c.73+805dup
NM_001322051.2:c.396dup
NR_136160.2:n.488dup

Pathogenic

Met criteria codes 3
PVS1 PP4 PM2_Supporting
Not Met criteria codes 1
PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ADA Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The c.396dup (p.Val133Serfs*38) (NM_000022.4) variant in ADA is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/12 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one patient with this variant displayed Diagnostic criteria for Leaky SCID (0.5pt) + T-B-NK- lymphocyte subset profile (0.5pt) = 1 point TOTAL, which is highly specific for SCID (PP4_Met, PMID: 21664875). In summary, this variant meets the criteria to be classified as pathogenic for SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: PVS1, PM2_Supporting, and PP4. (VCEP specifications version 1).
Met criteria codes
PVS1
The c.396dup (p.Val133Serfs*38) (NM_000022.4) variant in ADA is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/12 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PP4
At least one patient with this variant displayed Diagnostic criteria for Leaky SCID (0.5pt) + T-B-NK- lymphocyte subset profile (0.5pt) = 1 point TOTAL, which is highly specific for SCID (PP4_Met, PMID: 21664875).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Not Met criteria codes
PM3
PMID 21664875, patient #69: The patient was diagnosed with atypical SCID. The patient was compound heterozygous with another variant not yet curated by the SCID VCEP (c.780+1G>A: This variant will not be evaluated now because the pathogenic level was already reached.)
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.